Mats Heyman
Clinical trials sponsored by Mats Heyman, explained in plain language.
-
Massive new trial aims to beat childhood leukemia with smarter, safer treatment
Disease control Recruiting nowThis study is testing a new treatment plan for children and young adults (up to age 45) newly diagnosed with acute lymphoblastic leukemia (ALL). It combines successful approaches from previous studies to improve survival and reduce side effects. About 6,430 participants will be e…
Phase: PHASE3 • Sponsor: Mats Heyman • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New study lays groundwork for better leukaemia care in kids and young adults
Knowledge-focused Recruiting nowThis pilot study is for children and young adults (0-45 years) newly diagnosed with acute lymphoblastic leukaemia (ALL). It collects information from standard treatments to help set up a larger future study. The goal is to improve how care is delivered and prepare for testing new…
Sponsor: Mats Heyman • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC